Hayley Nguyen
Family Medicine · Houston, TXNPI 1376569582
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.9% of the total across 116 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 35.9% of the total. Reporting peaked in 2019 at $924 and has fallen 84.3% since, to $145 in 2025.
Across 116 payments — averaging $16.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$706
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$306
- Amgen$176
- Amarin Pharma, Inc.$156
- Lilly USA, LLC$144
- Takeda Pharmaceuticals U.S.A., Inc.$105
- plus $371 from 12 others
What the payments were for
- Consulting fees$1005%
- Food & beverage$1,86595%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 43 | $706 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 24 | $306 |
| Amgen | 16 | $176 |
| Amarin Pharma, Inc. | 3 | $156 |
| Lilly USA, LLC | 3 | $144 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $105 |
| Comsort, Inc | 1 | $100 |
| Arbor Pharmaceuticals, Inc. | 5 | $84 |
| Gilead | 2 | $31 |
| Merck | 4 | $30 |
| Genentech USA, Inc. | 2 | $28 |
| Bausch Health US, LLC | 1 | $18 |
| Pfizer | 1 | $17 |
| Shield Therapeutics Inc | 1 | $15 |
| IBSA Pharma Inc. | 1 | $12 |
| AstraZeneca | 1 | $12 |
| Sebela Pharmaceuticals Inc. | 1 | $12 |
| Currax Pharmaceuticals LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,965 in reported general payments places this provider in the 70th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Olmesartan Medoxomil | 14 | $456 |
| Atorvastatin Calcium | 15 | $227 |
| Levothyroxine Sodium | 11 | $184 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $127 |
| Diazepam | 12 | $29 |
| Prednisone | 14 | $21 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Houston
- Shannon SchraderHouston$216K
- Candice WinfulHouston$173K
- Guljeet SohalHouston$72K
- Lakecia PittsHouston$71K
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.